Researcher says engineered avian influenza virus isn't lethal

01/25/2012 | Bloomberg

The airborne version of highly pathogenic avian influenza strain H5N1 engineered at the University of Wisconsin at Madison is not fatal and can be treated by currently available medicines, said Yoshihiro Kawaoka, professor of virology and the study's lead researcher. Kawaoka halted his research following an agreement reached with federal officials over bioterrorism concerns related to the altered virus, but he argues that more research is urgently needed.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL